Article Text

Download PDFPDF
The nicotine inhaler was an effective and safe aid to smoking cessation

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

OpenUrlCrossRefPubMedWeb of Science


To evaluate the effectiveness and safety of the nicotine inhaler as an adjunct to group support in smoking cessation.


1 year, randomised, double blind, placebo controlled trial.


Smoking cessation clinic at a university hospital in Göteborg, Sweden.


247 persons who were ≥20 years of age (mean age 48 y, 64% women), smoked ≥10 cigarettes per day, smoked for ≥3 years, and had made a previous serious attempt to quit smoking using nicotine chewing gum. Exclusion criteria included severe cardiovascular disease; pregnancy; breast feeding; use of psychotropic drugs, smokeless tobacco, or snuff; abuse of alcohol or any other drugs during the past 12 months; nicotine replacement therapy during the past 12 months; and acute medical illness. Follow up was 94%.


Participants attended support sessions …

View Full Text


  • Source of funding: Pharmacia & Upjohn, Helsingborg, Sweden.

  • For article reprint: Dr A Hjalmarson, Smoking Cessation Clinic, Sahlgrenska University Hospital, 413 45 Goteborg, Sweden. Fax +46 31 416639.